CT-guided irreversible electroporation safe in unresectable pancreatic carcinoma

May 7, 2014

A small group of patients with locally advanced unresectable pancreatic carcinoma suffered no major ill effects—pancreatitis or fistula formation—after undergoing percutaneous CT-guided irreversible electroporation (IRE)—a nonthermal ablation technology that is safe near vascular and ductal structures—as a therapy.

"Our findings exceeded our expectations," said Maria Paola Belfiore, a researcher at the Institute of Radiology, Second University of Naples. "In fact, three patients were downstaged, and so had a greater life expectancy. This is a great new promise for inoperable tumors."

The ablation procedure was successful in 100 percent of the patients. These early results represent a good alternative to intraoperative IRE , and offer a safe and feasible primary local treatment for locally advanced pancreatic cancer.

Explore further: Electrical pulse treatment gives pancreatic cancer patients new hope

More information: Dr. Belfiore presented the study on May 6 at the 2014 ARRS Annual Meeting in San Diego, CA.

Related Stories

Electrical pulse treatment gives pancreatic cancer patients new hope

March 26, 2012
Results of a study presented at the Society of Interventional Radiology's 37th Annual Scientific Meeting in San Francisco, Calif., signal a light at the end of the tunnel for individuals with inoperable locally advanced pancreatic ...

New ablation technique holds promise for liver cancer patients

April 18, 2013
A new minimally invasive tumor ablation technique is providing hope for liver cancer patients who can't undergo surgery or thermal ablation, a study shows.

SPACE, RF ablation combo safe and effective for lung cancer

May 15, 2013
(HealthDay)—For unresectable lung tumors, the combination of segmental pulmonary arterial chemoembolization (SPACE) and percutaneous radiofrequency (RF) ablation helps achieve better local tumor progression rates than RF ...

Electrical pulse treatment pokes holes in hard-to-treat tumors

April 14, 2013
A new, minimally invasive treatment that tears microscopic holes in tumors without harming healthy tissue is a promising treatment for challenging cancers, suggests a preliminary study being presented at the Society of Interventional ...

Researcher identifies nearly 100 studies supporting use of thermal ablation to treat lung cancer

August 31, 2011
The journal Radiology will publish in its September issue an article written by Damian E. Dupuy, M.D., director of tumor ablation at Rhode Island Hospital, supporting the use of ablation procedures for the treatment of lung ...

Screen some patients with acute pancreatitis for pancreatic cancer, researchers suggest

February 26, 2014
In a study published in Clinical Gastroenterology and Hepatology, Saint Louis University researchers have found a link between acute pancreatitis (inflammation of the pancreas) and pancreatic cancer, a finding which may eventually ...

Recommended for you

New therapeutic approach for difficult-to-treat subtype of ovarian cancer identified

July 24, 2017
A potential new therapeutic strategy for a difficult-to-treat form of ovarian cancer has been discovered by Wistar scientists. The findings were published online in Nature Cell Biology.

Anti-cancer chemotherapeutic agent inhibits glioblastoma growth and radiation resistance

July 24, 2017
Glioblastoma is a primary brain tumor with dismal survival rates, even after treatment with surgery, chemotherapy and radiation. A small subpopulation of tumor cells—glioma stem cells—is responsible for glioblastoma's ...

Immune cells the missing ingredient in new bladder cancer treatment

July 24, 2017
New research offers a possible explanation for why a new type of cancer treatment hasn't been working as expected against bladder cancer.

No dye: Cancer patients' gray hair darkened on immune drugs

July 21, 2017
Cancer patients' gray hair unexpectedly turned youthfully dark while taking novel drugs, and it has doctors scratching their heads.

Shooting the achilles heel of nervous system cancers

July 20, 2017
Virtually all cancer treatments used today also damage normal cells, causing the toxic side effects associated with cancer treatment. A cooperative research team led by researchers at Dartmouth's Norris Cotton Cancer Center ...

Immune-cell numbers predict response to combination immunotherapy in melanoma

July 20, 2017
Whether a melanoma patient will better respond to a single immunotherapy drug or two in combination depends on the abundance of certain white blood cells within their tumors, according to a new study conducted by UC San Francisco ...

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.